Imprivata, a health IT security developer, is being acquired by Thoma Bravo for approximately $544 million. This strategic move aims to enhance product offerings and position the company for market growth. Thoma Bravo’s experience in security and healthcare IT is seen as beneficial for Imprivata’s mission critical technologies. Shareholders will receive $19.25 per share in cash, a 33% premium.

JPMorgan Chase & Co. CISO writes open letter to third-party suppliers
Patrick Opet, CISO at JPMorgan Chase & Co., issues an open letter to third-party suppliers, emphasizing the importance of cybersecurity practices. He stresses the need